Lupin Limited (LUPIN) — Corporate Action | 14 May 2025

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

{ "summary": "Lupin Limited reported a 69.9% YoY revenue jump to ₹16,458.58 crores for FY2025, driven by strong performance in its consolidated results, with net profit reaching ₹3,972.96 crores — up 69.9% year-on-year — while declaring a dividend of ₹12 per share (600% of ₹2 face value), subject to shareholder approval at the upcoming AGM.", "extractedFields": { "keyEvent": "Lupin Limited declares ₹12 per share dividend (600% of ₹2 face value) for FY2025, subject to AGM approval.", "whatChanged": "Net profit surged 69.9% YoY to ₹3,972.96 crores; revenue grew 69.9% YoY to ₹16,458.58 crores; impairment charges recorded; paid-up capital increased by 0.7 million shares.", "forwardGuidance": "AGM to be held to approve dividend; divestments of OTC and API R&D businesses underway; share capital movements continue via ESOPs and allotments.", "investorTakeaway": "Strong profitability growth and high dividend payout signal robust financial health, but divestment execution and future growth sustainability require monitoring.", "sentiment": "positive" }, "dividendPerShare": 12, "dividendPercentage": 600, "faceValue": 2, "recommendedDividendSubjectToAGM": true, "boardMeetingDate": "2025-05-14", "agmDate": null, "auditedFinancialsPeriodEnd": "2025-03-31", "revenueQ42025": 43826.9, "revenueYear2025": 164585.8, "netProfitQ42025": 12913.5, "netProfitYear2025": 39729.6, "totalComprehensiveIncomeQ42025": 12797.2, "totalComprehensiveIncomeYear2025": 39584.9, "earningsPerShareBasicQ42025": 28.30, "earningsPerShareBasicYear2025": 87.10, "earningsPerShareDilutedQ42025": 28.21, "earningsPerShareDilutedYear2025": 86.79, "sharesAllottedUnderESOPsQ42025": 330503, "sharesAllottedUnderESOPsYearToDate2025": 886137, "paidUpEquityShareCapitalMillion": 913.2, "otherEquityMillion": 241869.2, "impairmentChargeQ": null, "companyName": "Lupin Limited", "exchange": "NSE", "filingDate": "2025-05-14", "filingType": "corporate_action", "auditPeriodEnd": "31/03/2025", "auditedFigures": { "revenueFromOperations": 221921.1, "totalRevenue": 227079.0, "totalIncome": 229037.2, "totalExpenses": 188887.2, "profitBeforeTax": 40150.0, "taxExpense": 7087.4, "profitAfterTax": 33062.6, "otherComprehensiveIncome": 376.0, "totalComprehensiveIncome": 32147.9, "profitAttributableToOwners": 32816.2, "earningsPerShareBasic": 71.95 }, "unauditedQuarterlyFigures": { "Q1FY2025": { "revenueFromOperations": 55622.0, "totalRevenue": 56671.3, "totalExpenses": 48282.4, "profitBeforeTax": 8958.4, "taxExpense": 1134.6, "profitAfterTax": 7823.8 }, "Q1FY2024": { "revenueFromOperations": 56185.6, "totalRevenue": 57269.5, "totalExpenses": 48855.5, "profitBeforeTax": 8314.1, "taxExpense": 1054.5, "profitAfterTax": 7259.6 } }, "dividendRecommended": "12/- per equity share (face value 2/- each), aggregating 5,478.8 million", "totalRevenue": "56,671.3 million (2025), 57,677.1 million (2024)", "profitBeforeTax": "40,150.0 million (2025), 24,222.7 million (2024)", "totalAssets": "292,048.8 million (as of 31/03/2025), 239,971.8 million (as of 31/03/2024)", "totalEquity": "172,943.5 million (as of 31/03/2025), 143,734.5 million (as of 31/03/2024)", "totalLiabilities": "119,105.3 million (as of 31/03/2025), 96,237.3 million (as of 31/03/2024)", "cashAndCashEquivalentsEnd": "15,436.9 million (as of 31/03/2025), 9,837.6 million (as of 31/03/2024)", "shareAllotmentImpact":

📄 View Original Announcement (PDF)

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

📊 More LUPIN filings

See all LUPIN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LUPIN — Free

Free account · 2 AI queries/day